Baker Bros. Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.78M Sell
2025
Q1
$2.57M Hold
2024
Q4
$5.38M Buy
2024
Q3
$10.5M Hold
2024
Q2
$9.83M Buy
2024
Q1
$13.3M Buy
2023
Q3
Sell
2023
Q2
$7.96M Hold
2023
Q1
$9.53M Buy
2022
Q4
$2.18M Hold
2022
Q3
$4.83M Buy